Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3644

1.

Modifications in Retinal Mitochondrial Respiration Precede Type 2 Diabetes and Protracted Microvascular Retinopathy.

Han WH, Gotzmann J, Kuny S, Huang H, Chan CB, Lemieux H, Sauvé Y.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3826-3839. doi: 10.1167/iovs.17-21929.

PMID:
28763556
2.

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.

Wysham C, Bhargava A, Chaykin L, de la Rosa R, Handelsman Y, Troelsen LN, Kvist K, Norwood P.

JAMA. 2017 Jul 4;318(1):45-56. doi: 10.1001/jama.2017.7117.

PMID:
28672317
3.

Implementation of a referral to discharge glycemic control initiative for reduction of surgical site infections in gynecologic oncology patients.

Hopkins L, Brown-Broderick J, Hearn J, Malcolm J, Chan J, Hicks-Boucher W, De Sousa F, Walker MC, Gagné S.

Gynecol Oncol. 2017 Aug;146(2):228-233. doi: 10.1016/j.ygyno.2017.05.021. Epub 2017 May 20.

PMID:
28532856
4.

The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes.

Hjuler ST, Gydesen S, Andreassen KV, Karsdal MA, Henriksen K.

J Pharmacol Exp Ther. 2017 Jul;362(1):24-30. doi: 10.1124/jpet.117.241281. Epub 2017 Apr 24.

PMID:
28438778
5.

Vitamin D status and its association with insulin resistance among type 2 diabetics: A case -control study in Ghana.

Fondjo LA, Owiredu WKBA, Sakyi SA, Laing EF, Adotey-Kwofie MA, Antoh EO, Detoh E.

PLoS One. 2017 Apr 19;12(4):e0175388. doi: 10.1371/journal.pone.0175388. eCollection 2017.

6.
7.

DPP-4 inhibitor treatment: β-cell response but not HbA<sub>1c</sub> reduction is dependent on the duration of diabetes.

Kozlovski P, Bhosekar V, Foley JE.

Vasc Health Risk Manag. 2017 Mar 31;13:123-126. doi: 10.2147/VHRM.S125850. eCollection 2017.

8.

Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences.

von Arx LB, Johnson FR, Mørkbak MR, Kjær T.

Value Health. 2017 Apr;20(4):670-678. doi: 10.1016/j.jval.2016.11.023. Epub 2017 Feb 9.

PMID:
28408010
9.

Resistant Starch but Not Enzymatically Modified Waxy Maize Delays Development of Diabetes in Zucker Diabetic Fatty Rats.

Hedemann MS, Hermansen K, Pedersen S, Bach Knudsen KE.

J Nutr. 2017 May;147(5):825-834. doi: 10.3945/jn.116.243899. Epub 2017 Mar 15.

PMID:
28298535
10.

Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial.

Samadi N, Mozaffari-Khosravi H, Rahmanian M, Askarishahi M.

J Integr Med. 2017 Mar;15(2):124-134. doi: 10.1016/S2095-4964(17)60315-7.

PMID:
28285617
11.

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

Scheen AJ.

Expert Opin Pharmacother. 2017 Apr;18(5):503-515. doi: 10.1080/14656566.2017.1297424. Epub 2017 Mar 1. Review.

PMID:
28276972
12.

Characteristics and Impact Factors of Renal Threshold for Glucose Excretion in Patients with Type 2 Diabetes Mellitus.

Yue XD, Wang JY, Zhang XR, Yang JH, Shan CY, Zheng MY, Ren HZ, Zhang Y, Yang SH, Guo ZH, Chang B, Chang BC.

J Korean Med Sci. 2017 Apr;32(4):621-627. doi: 10.3346/jkms.2017.32.4.621.

13.

Nitric oxide levels in response to the patients with different stage of diabetes.

Ozcelik O, Algul S.

Cell Mol Biol (Noisy-le-grand). 2017 Feb 22;63(1):49-52. doi: 10.14715/cmb/2017.63.1.10.

PMID:
28234625
14.

Real-World Glycemic Control from GLP-1RA Therapy with and Without Concurrent Insulin in Patients with Type 2 Diabetes.

Singhal M, Unni S, Schauerhamer M, Nguyen H, Hurd J, McAdam-Marx C.

J Manag Care Spec Pharm. 2017 Mar;23(3):267-275. doi: 10.18553/jmcp.2017.16334. Epub 2017 Feb 6.

15.

Daily Intake of Trehalose Is Effective in the Prevention of Lifestyle-Related Diseases in Individuals with Risk Factors for Metabolic Syndrome.

Mizote A, Yamada M, Yoshizane C, Arai N, Maruta K, Arai S, Endo S, Ogawa R, Mitsuzumi H, Ariyasu T, Fukuda S.

J Nutr Sci Vitaminol (Tokyo). 2016;62(6):380-387. doi: 10.3177/jnsv.62.380.

17.

Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.

Parsons S, Luzio S, Bain S, Harvey J, McKenna J, Khan A, Rice S, Watkins A, Owens DR.

BMC Endocr Disord. 2017 Jan 26;17(1):4. doi: 10.1186/s12902-017-0154-x.

18.

Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes.

Aronoff SL.

Postgrad Med. 2017 Mar;129(2):231-241. doi: 10.1080/00325481.2017.1285191. Epub 2017 Feb 8. Review.

PMID:
28118069
19.
20.

Supplemental Content

Loading ...
Support Center